Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications

Keyphrases

• Clinical Application 100%
• Pharmacogenetics 100%
• Evidence-based 100%
• Child Psychiatry 100%
• Adolescent Psychiatry 100%
• Pharmacogenetic Testing 66%
• Pharmacokinetics 33%
• Tolerability 33%
• Antipsychotics 33%
• Pharmacodynamics 33%
• Antidepressants 33%
• Treatment Outcome 33%
• Stimulants 33%
• Clinical Decision-making 33%
• Adverse Drug Reaction 33%
• Current Guidelines 33%
• Clinical Considerations 33%
• United States Food 33%
• Clinical Decision Support Systems 33%
• Alpha-2 Agonists 33%
• PGx Testing 33%
• Clinical Pharmacogenetics Implementation Consortium 33%
• Dutch Pharmacogenetics Working Group 33%
• Serotonin-norepinephrine Reuptake Inhibitors 33%

Nursing and Health Professions

• Adolescent 100%
• Psychotropic Agent 100%
• Drug Therapy 100%
• Pharmacogenetic Testing 100%
• Typical Antipsychotic 50%
• Practice Guideline 50%
• Treatment Outcome 50%
• Clinician 50%
• Food and Drug Administration 50%
• Antidepressant 50%
• Central Stimulant Agent 50%
• Clinical Decision Support System 50%
• Clinical Decision Making 50%
• Pharmacodynamics 50%
• Norepinephrine Reuptake Inhibitor 50%
• Base 50%
• Adverse Drug Reaction 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacogenetics 100%
• Psychotropic Agent 28%
• Pharmacodynamics 14%
• Tolerability 14%
• Antidepressant 14%
• Drug Administration 14%
• Adverse Drug Reaction 14%
• Norepinephrine Reuptake Inhibitor 14%
• Pharmacokinetics 14%
• Base 14%
• Typical Antipsychotic 14%